Business continuity plans adopted by the Commercial Court
Today, The Commercial Court of Mont de Marsan issued its decision, following the hearing held on July 16 and adopted the continuation plans submitted by Europlasma Group companies.
Read the press release (in French)
General Management strengthened: Olivier Pla appointed as Deputy Chief Executive Officer of the Group
Olivier Pla is recruited as Deputy Chief Executive Officer (employee) of the Europlasma group, with a start today.
Read the press release (in French)
Observation period maintained
The Commercial Court of Mont-de-Marsan maintains the observation period in order to allow the presentation of the draft recovery plan set up by Zigi Capital.
Read the press release (in French)
Update on legal proceedings progress
During the hearing on May 9, 2019, the Commercial Court of Mont de Marsan examined three proposals for takeover of activity submitted by candidates.
Read the press release (in French)
Update on legal proceedings progress
On April 22, 2019, set by the Commercial Court of Mont de Marsan for the submission of a takeover offer, one potential buyer submitted an improved offer to take over part of the activities of Europlasma Group as well as part of the employees.
Read the press release (in French)
Update on legal proceedings progress
According to the judgment of 25 January 2019 declaring the opening of the insolvency proceedings of Europlasma and the Group companies (see press release of 25/01/2019), the Commercial Court of Mont de Marsan set an observation period of 6 months to implement sustainable industrial projects and safeguard jobs.
Read the press release (in French)
Details concerning BSAR exercise
As part of the ongoing proceedings, Europlasma recalls that the share price as well as BSAR B and C of the Company have been suspended since 20 March 2019.
Read the press release (in French)
Legal proceedings update
As part of the ongoing proceedings (see press release of 25/01/2019), the Commercial Court of Mont de Marsan decided, by its judgment of January 25, 2019, to set up a period of observation of 6 months and scheduled a follow-up session on March 22, 2019.
Read the press release (in French)
Europlasma shares trading is suspended pending a press release
Europlasma asked Euronext Paris to suspend the trading of its shares (FR0000044810-ALEUP) from today at 9:00am (Paris time).
Read the press release (in French)